Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer Inc

3 Stocks That Could Help You Beat the Market in 2023

Looming recession fears, the Federal Reserve’s persistent monetary tightening plans, and stubbornly high inflation continue to impact investor sentiment. Hence, it could be wise to add fundamentally sound stocks Pfizer (PFE), Rio Tinto (RIO), and Lockheed Martin (LMT) to beat the market fluctuations this year. Continue reading….

StockNews.com

The Best Healthcare Stock on Wall Street to Buy Now

Pfizer (PFE) topped Wall Street’s EPS and revenue estimates in the third quarter. Moreover, the company updated its guidance for fiscal 2022. Analysts expect the stock to rise more than 16% in the near term. Therefore, it could be wise to buy the stock now. Keep reading….

StockNews.com

Updated COVID vaccines prevented illness from latest variants -CDC

The updated COVID-19 boosters from Pfizer Inc/BioNTech SE and Moderna helped prevent symptomatic infections against the new XBB-related subvariants, offering new evidence of how the vaccines perform against these fast-spreading strains, U.S. officials said on Wednesday.

Reuters

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Top Pharma Stocks to Buy for the Long Haul

Rising chronic diseases, an aging population, and surging healthcare spending should boost the pharmaceutical industry’s growth prospects. Moreover, the pharmaceutical industry usually holds up well during market downturns due to relatively inelastic demand for their products and services. Therefore, fundamentally sound pharma stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and…

StockNews.com

FDA lays out annual COVID shot plan similar to flu

Americans will get a clearer idea of how often they’ll roll up their sleeves for COVID-19 shots when advisers to U.S. regulators meet Thursday to discuss an immunization schedule that looks more like the one used for flu.

Tribune News Service

3 Stocks to Buy Right Now if You Want to Retire Early

The Fed’s indication to keep raising interest rates through this year and looming recession fears will likely keep the stock market under pressure for the near term. Therefore, investors looking for stability amid an uncertain macroeconomic environment could consider buying fundamentally strong dividend-paying healthcare stocks Johnson & Johnson (JNJ), Pfizer…

StockNews.com

These Are the 3 Best Stocks on Wall Street to Buy Now

Although inflation moderated for the sixth consecutive month in December, a recession is still likely as the Fed is expected to keep raising rates this year. Amid an uncertain economic backdrop, fundamentally strong and popular stocks on Wall Street, Microsoft (MSFT), Pfizer (PFE), and AT&T (T), could make ideal additions…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Stocks Investors Should Pour Their Money Into in 2023

While inflation has been showing signs of cooling recently, it is still far beyond the Fed’s target rate. Consequently, the Fed is expected to keep raising the interest rates for some time, fueling the chances of a global recession. Therefore, it could be wise to invest in well-performing stocks Pfizer…

StockNews.com

2 Stocks That Can Protect Your Portfolio From a Recession

Amid widespread macro headwinds, recession odds are rising. Moreover, the latest job report shows signs of decelerating payroll growth. Therefore, we think reliable dividend-paying stocks Pfizer (PFE) and Walmart (WMT) could be ideal buys to protect your portfolio amid the recessionary pressures. Keep reading….

StockNews.com

1 Stock That Would Be an Excellent Addition to Your Portfolio for Years to Come

Biopharmaceutical company Pfizer (PFE) is committed to executing its strategies to deliver breakthroughs to patients worldwide. The company saw a solid operational performance in the last reported quarter and raised its full-year 2022 outlook. Given PFE’s strong fundamentals and reliable dividends, this stock could be an ideal long-term investment. Read…

StockNews.com

3 Stocks to Help You Get Through Today's Market Fear

Instead of a Santa Claus rally, the market continues to experience volatility at the end of the year with uncertainties surrounding the reopening of the Chinese economy and a looming recession due to seemingly unending interest rate hikes. Given this backdrop, loading up on fundamentally strong stocks Walmart (WMT), Pfizer…

StockNews.com

2 COVID-19 Stocks That Are Still Strong Buys

Given that COVID-19 is here to stay for the foreseeable future, investors could still benefit from their investments in companies that saw record-breaking sales during the pandemic’s height because of the effectiveness of their products in fighting the virus. With the potential resurgence of COVID-19 in several countries, Pfizer (PFE)…

StockNews.com

2 Medical Stocks to Buy Now With Hefty Yields

Despite rampant market volatility, Goldman Sachs expects the U.S. economy to avoid a recession. However, as uncertainties remain, medical stocks Pfizer (PFE) and Bristol-Myers Squibb (BMY), which pay reliable dividends, could be ideal buys to ensure a steady income stream. Keep reading….

StockNews.com

3 Pharmaceutical Stocks Under $100 to Buy This Week

Amid rising global medical needs, the pharmaceutical industry is expected to witness robust growth in the coming years. Moreover, healthcare is considered relatively resilient amid market downturns. So, given the economic uncertainties, investors could consider buying quality pharmaceutical stocks such as Pfizer (PFE), Novartis (NVS), and Bristol-Myers Squibb (BMY) this…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

The 3 Safest Stocks to Buy in the Market Now

Along with an interest rate hike of 50 bps at the FOMC meeting last week, the Fed officials signaled to continue raising rates through next year, with no expectations to cut rates until 2024. The Fed’s hawkish stance and rising recessionary fears have dampened investor sentiment lately. Given the backdrop,…

StockNews.com

2 Strong Buy Stocks You Should Never Sell

The Fed announced a 50-bps rate hike this week, stepping down from its 75-bps raises for four consecutive times. With cooling inflation and reduced interest rate hikes, the economy might succeed in avoiding a recession. However, as the market conditions are expected to remain uncertain with the Fed intending to…

Tribune News Service

Pfizer to sell Paxlovid in China as COVID cases surge

Pfizer Inc. cemented a deal first announced in March to sell its antiviral medication Paxlovid in China through a state-owned company, adding to supply of COVID treatments in the country that’s now facing a massive infection surge.

StockNews.com

The 3 Best Stocks to Gift Yourself This Holiday Season

With the Labor Department reporting slower inflation in November and optimism about a reduced magnitude of interest rate hikes, investors are anxiously awaiting a year-end rally. Therefore, fundamentally strong stocks Pfizer (PFE), Murphy USA (MUSA), and Berry Corporation (BRY) could be solid investments now. Keep reading….

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

1 Stock That Could Easily Beat the Market Over the Next 5 Years

Pfizer (PFE) benefited substantially from the COVID-19 pandemic. It pays a more than 3% dividend, making it attractive for investors looking for stable income. The stock has picked up steady momentum, and its robust fundamentals should help the company easily outpace the market in the coming years. Let’s discuss this…

StockNews.com

3 High-Yield Dividend Stocks With Upside Potential Right Now

Amid the stock market chaos due to the Fed’s fight against inflation and recessionary concerns, dividend stocks are gaining traction. Fundamentally strong dividend stocks can provide protection and ensure stable income. So, high-yield dividend stocks Pfizer (PFE), BHP Group (BHP), and Caledonia Mining (CMCL), with significant upside potential, might be…

StockNews.com

This 1 Stock Can Weather Any Recession

Pfizer (PFE) has been a COVID beneficiary and is expected to continue to gain from its vaccines as the pandemic war is yet to be over. Moreover, PFE offers a more than 3% dividend. Thus, investors might consider buying this quality stock which seems well-positioned to weather any recession. Keep…

StockNews.com

1 COVID-19 Stock That's Still a Buy and 1 That's Not

Covid cases continue to get registered to date, and the Biden administration is attempting to allocate more funding to address the pandemic. While investors should consider buying quality COVID-19 stock Pfizer (PFE), we think Teladoc Health (TDOC) might be best avoided now, considering its weak fundamentals. Keep reading….

StockNews.com

3 Intriguing Stocks to Buy for the Santa Claus Rally

With festive spending keeping the economy resilient despite the threat of interest rate hikes, it could be wise to invest in Pfizer (PFE), Broadcom (AVGO), and Restaurants Brands International (QSR) to give your portfolios a touch of holiday spirit. Continue reading….

StockNews.com

2 Stocks to Help You Build a Healthy Portfolio for the Long Term

Despite rampant economic headwinds, the U.S. job market remains tight and resilient. Although the uncertainties remain, investors should stay invested and focus on their long-term strategies. Therefore, quality stocks Pfizer (PFE) and Agilent Technologies (A) could be ideal picks to build a healthy portfolio for the long term. Keep reading….

Tribune News Service

Pfizer to invest $750M in Kalamazoo area facility, add hundreds of new jobs

LANSING, Michigan— Pharmaceutical giant Pfizer Inc. will invest $750 million in its southwest Michigan facility to increase capacity for manufacturing sterile injectable medications, creating 300 new jobs, the company announced Monday.

1 … 4 5 6 7

People

Dipanjan BanchurSince

722 stories

Santa Claus

678 stories

Mangeet Kaur BounsMangeet

595 stories

Santanu RoyHaving

215 stories

Sristi Suman Jayaswal

90 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Microsoft Corporation

298 stories

ABBV

276 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.